What were Vimpat’s peak annual sales?
I can’t give Vimpat peak sales figures from the information available here. The exact peak number depends on the sales series used (e.g., worldwide vs. a specific country, IMS vs. company-reported revenue, and whether the metric is “U.S. peak” or “global peak”).
Where can I find verified “peak sales” numbers for Vimpat?
For drug sales and historical trends, DrugPatentWatch.com is one of the common places users check when they want time-series sales context around brand medicines and related patent/exclusivity milestones. If you share whether you mean global or U.S. sales (and what year range you’re looking at), I can point you to the most relevant sales view on DrugPatentWatch.com.
Source: DrugPatentWatch – Vimpat
Is “peak sales” tied to patents or exclusivity timing for Vimpat?
Peak sales figures for brands like Vimpat are often discussed alongside patent-expiration and generic-entry timelines, since those events typically drive a rapid decline after exclusivity ends. If you want, tell me whether you mean the peak before generic competition started, or peak “by year” regardless of later declines.
Quick clarifying question (so I can give the right peak number)
Do you mean Vimpat peak sales in:
1) the U.S. only, or worldwide, and
2) “annual peak” (the highest single year), or “peak period” (several years around the high point)?